Patient P-02087
Therapy response
Unstable
Tolerance
Favorable
GI state
Favorable
Inflammatory state
Favorable
Nutritional resilience
Declining
Discontinuation risk
25%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 META-24 started — Baseline state S01
- Day 108 BR-03 recommended — Behavioural Recommendation BR-03
- Day 109 Patient accepted — Started BR-03 in the companion
- Day 116 No meaningful change — Behavioural Recommendation BR-03
- Day 123 Trajectory diverged from prediction — Observed response fell below the model's expected path.
What changed?
Trajectory began diverging from predicted response on Day 123.
Primary contributors, last 14 days
- Nutritional resilience-5
- GI instability+4
- Toxicity+3
- Treatment adherence+2
What helped?
- Behavioural Recommendation BR-03Day 108Result: no meaningful change
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients.
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Autonomic recovery ↓45
- WearableResting HR 75 bpm
- WearableShort sleep window
- Mucosal barrier integrity ↓40
- MicrobiomeAkkermansia low → thinner mucus layer
- WearableSleep 5.7 h, below personal baseline
- Drug metabolism and exposure ↑40
- DNACYP2D6 poor metabolizer → higher exposure
- Butyrate / short-chain fatty acid production ↓25
- MicrobiomeF. prausnitzii depleted
- Inflammatory signalling ↓20
- MicrobiomeBacteroides fragilis expansion
DNA
Fictional pharmacogenomic panel
- CYP2D6 Poor metabolizerHigher exposure at standard dose
Microbiome
Shannon diversity 4.2 · butyrate capacity 45/100
- Akkermansia muciniphilaLow
- Faecalibacterium prausnitziiLow
- Bacteroides fragilisHigh
- Bifidobacterium longumLow
- EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 58 ms
- Sleep
- 5.9 h
- Steps
- 9,148
- Resting HR
- 77 bpm
Daily log: GI score 26, nutritional resilience 61, adherence 86.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
- Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
- Log the daily check-in; one line is enough
- Keep the current walking rhythm
- Protect a 7.5-hour sleep window; screens off 30 minutes before
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the dose at the same time relative to your evening meal
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.
| Patient | Similarity | Baseline | Intervention | Outcome | Response today |
|---|---|---|---|---|---|
| P-02093 | 49% | S05 | AD-05 | no change | 40 |
| P-02285 | 49% | S14 | AD-05 | no change | 39 |
| P-02522 | 47% | S01 | BR-03 | no change | 40 |
| P-02416 | 46% | S04 | — | — | 37 |
| P-02465 | 46% | S04 | — | — | 46 |
| P-02625 | 46% | S15 | — | — | 36 |
| P-02088 | 45% | S04 | — | — | 44 |
| P-02259 | 45% | S15 | — | — | 37 |
| P-02638 | 45% | S01 | BR-03 | improved | 41 |
| P-02161 | 44% | S13 | — | — | 28 |
| P-02308 | 44% | S13 | BR-03 | no change | 27 |
| P-02341 | 44% | S12 | — | — | 33 |